To explore the potential of LOXL2 as a biomarker in glioma and construct a genomic integrated clinical prognostic model
{{output}}
Background: Glioma is a common invasive tumor of the central nervous system, and its pathological features significantly impair the quality of life of patients, with high mortality risk and easy recurrence. For glioma Lysine Oxid... ...
